GRI
Price:
$2.25
Market Cap:
$202.12K
GRI Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutic agents within the United States. Its primary focus lies in addressing inflammatory, fibrotic, and autoimmune disorders. The company's leading drug candidate is GRI-0621, an oral inhibitor targeting type 1 Natural Killer T cells, which is currently undergoing Phase IIa clinical trials. This investigational treatment is being evaluated for severe fibrotic lung conditions, including idiopathic pulmonary fibrosis. Beyond its flagship program, GRI Bio's pipeline also features GRI-0803, a novel oral agonist designed to activate type 2 Natural Killer T cells, cur...[Read more]
Industry
Biotechnology
IPO Date
2023-04-24
Stock Exchange
NASDAQ
Ticker
GRI
According to GRI Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -10787878.00. This represents a change of 163.10% compared to the average of -4100372.96 of the last 4 quarters.
The mean historical Enterprise Value of GRI Bio, Inc. over the last ten years is 14.63B. The current -10787878.00 Enterprise Value has changed -107.38% with respect to the historical average. Over the past ten years (40 quarters), GRI's Enterprise Value was at its highest in in the December 2020 quarter at 8.80B. The Enterprise Value was at its lowest in in the March 2026 quarter at -8148110.00.
Average
14.63B
Median
4.62B
Minimum
-7479700.58
Maximum
90.16B
Discovering the peaks and valleys of GRI Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 924.59%
Maximum Annual Enterprise Value = 90.16B
Minimum Annual Increase = -109.50%
Minimum Annual Enterprise Value = -7479700.58
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -7479700.58 | 221.25% |
| 2024 | -2328304.96 | -109.50% |
| 2023 | 24.52M | -94.40% |
| 2022 | 437.81M | -99.51% |
| 2021 | 90.16B | 924.59% |
| 2020 | 8.80B | 0.04% |
| 2019 | 8.80B | -0.03% |
The current Enterprise Value of GRI Bio, Inc. (GRI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.90M
5-year avg
18.12B
10-year avg
14.63B
GRI Bio, Inc.’s Enterprise Value is less than CNS Pharmaceuticals, Inc. (91.17K), less than Jaguar Health, Inc. (27.21M), less than Silo Pharma, Inc. (2.10M), less than Biodexa Pharmaceuticals Plc (-6777847.98), less than Abpro Corporation (-4541200.00), less than InMed Pharmaceuticals Inc. (-2005797.00), less than Can-Fite BioPharma Ltd. (7.43B), less than 60 Degrees Pharmaceuticals, Inc. (-2088883.00), greater than Genprex, Inc. (-17004550.00), less than Calidi Biotherapeutics, Inc. (-3842430.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 91.17K | $2.81M | |
| 27.21M | $179.26K | |
| 2.10M | $6.00M | |
| -6777847.98 | $2.26M | |
| -4541200.00 | $1.06M | |
| -2005797.00 | $2.73M | |
| 7.43B | $1.53M | |
| -2088883.00 | $1.10M | |
| -17004550.00 | $1.04M | |
| -3842430.00 | $1.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GRI Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GRI Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GRI Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for GRI Bio, Inc. (GRI)?
What is the 3-year average Enterprise Value for GRI Bio, Inc. (GRI)?
What is the 5-year average Enterprise Value for GRI Bio, Inc. (GRI)?
How does the current Enterprise Value for GRI Bio, Inc. (GRI) compare to its historical average?